Article Name Artificial Intelligence
New platform is designed to enable fast, scalable access to a wide range of AI imaging solutions
14th November, 2025
The collaboration reflects a growing global shift toward connected care where the patient journey no longer ends at recovery but evolves into sustained, data-powered wellness management
14th November, 2025
By integrating intraoperative data from Proprio's Paradigm platform with the Harms Study Group registry, the partnership ushers in a new era of quantitative, AI-enabled spine surgery research
13th November, 2025
Laronix is also developing MIRA-AI, the Company's latest offering, which effectively creates an ultra-realistic voice for the patient using advanced AI
13th November, 2025
Collaboration aims to expand existing U.S. relationship combining GE HealthCare’s mammography systems with DeepHealth’s Breast Suite to include a worldwide distribution arrangement
13th November, 2025
The collaboration sets a new standard for diagnostic accuracy and clinical efficiency
12th November, 2025
These strengths provide the platform for the development of devices and services tailored to frontline clinical workflows
12th November, 2025
This initiative is firmly aligned with the Government of India’s vision of Viksit Bharat 2047
11th November, 2025
AI-driven clinical tools has made reliability, uptime, and patient safety more critical than ever
11th November, 2025
AI tools improve mammography by supporting radiologists, enhancing cancer detection accuracy rates and reducing chances of errors such as false positives, false negatives, further helping to optimise workflow
10th November, 2025
The rebranding marks the first phase of Lunit's unified global identity, connecting breast health, AI detection, and precision oncology under one name
07th November, 2025
Landmark collaboration with Caristo Diagnostics positions NCH at the forefront of preventive cardiology
06th November, 2025
It provides an immersive, continuous view while I operate in an upright posture
05th November, 2025
The Company's next-generation diagnostics technology, enhanced by proprietary AI models, enables real-time PCR diagnostics at the point-of-care
04th November, 2025
The successful filing of the XJ LLM represents a milestone in Fangzhou’s AI-enabled chronic disease management ecosystem
03rd November, 2025
Dosimetry portfolio strengthened with Medical Imaging QA and AI validation
03rd November, 2025
Through this collaboration, Fangzhou’s AI Health Manager will offer personalised care guidance and monitoring
31st October, 2025
Testing to focus on the potential to deliver real-time, AI-powered insights that improve patient outcomes and support continuous learning for surgeons
30th October, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer